We conducted an expansive FTO review of the bi-specific antibody space for a small client seeking to be acquired by a high-profile organization in the same space. We screened thousands of results to help determine the client’s freedom to operate. Based on our…
A Japanese-based client in a multi-million dollar deal sought to acquire a U.S. based company that makes medical devices (“the Technology”). The due diligence of the target company and the Technology included a thorough review of the entire IP portfolio and related files.…
Drafting and filing applications directed to nanoparticle delivery composition systems involving bi-specific antibodies, where the nanoparticle contains both an antihistamine and a FcԑRI targeting moiety. The targeting moiety binds the nanoparticle to a target cell and blocks target cell degranulation mediated by FcԑRI…